Activation of the T-Cell Oncogene LMO2 after Gene Therapy for X-Linked Severe Combined Immunodeficiency

Matthew P. McCormack, Terence H. Rabbitts

Research output: Contribution to journalReview ArticleResearchpeer-review

211 Citations (Scopus)
Original languageEnglish
Pages (from-to)913-922
Number of pages10
JournalNew England Journal of Medicine
Volume350
Issue number9
DOIs
Publication statusPublished - 26 Feb 2004
Externally publishedYes

Cite this

@article{5b0023172e024c6994f61b0cd532e7f5,
title = "Activation of the T-Cell Oncogene LMO2 after Gene Therapy for X-Linked Severe Combined Immunodeficiency",
author = "McCormack, {Matthew P.} and Rabbitts, {Terence H.}",
year = "2004",
month = "2",
day = "26",
doi = "10.1056/NEJMra032207",
language = "English",
volume = "350",
pages = "913--922",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "9",

}

Activation of the T-Cell Oncogene LMO2 after Gene Therapy for X-Linked Severe Combined Immunodeficiency. / McCormack, Matthew P.; Rabbitts, Terence H.

In: New England Journal of Medicine, Vol. 350, No. 9, 26.02.2004, p. 913-922.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Activation of the T-Cell Oncogene LMO2 after Gene Therapy for X-Linked Severe Combined Immunodeficiency

AU - McCormack, Matthew P.

AU - Rabbitts, Terence H.

PY - 2004/2/26

Y1 - 2004/2/26

UR - http://www.scopus.com/inward/record.url?scp=1342289322&partnerID=8YFLogxK

U2 - 10.1056/NEJMra032207

DO - 10.1056/NEJMra032207

M3 - Review Article

VL - 350

SP - 913

EP - 922

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 9

ER -